Notably, the better preserved Serca2a and RyR2 expression in Miat-KO mice precedes the alleviation of cardiac hypertrophy, suggesting a causal role of Miat-mediated Serca2a and RyR2 downregulation in the pathogenesis of cardiac hypertrophy. Here, MIAT is linked to cardiac hypertrophy.